Alpinetin is primarily used in pharmaceutical and medicinal research due to its anti-inflammatory and antioxidant properties. It has shown potential in inhibiting pro-inflammatory cytokines, making it a candidate for developing treatments for inflammatory diseases such as arthritis and colitis. Studies also indicate that alpinetin may possess anticancer activity by inducing apoptosis in certain cancer cell lines, particularly in gastric and liver cancers. Additionally, it exhibits antimicrobial effects against various pathogens, supporting its traditional use in treating infections. Its ability to modulate signaling pathways like NF-κB and MAPK further highlights its therapeutic relevance in chronic disease management. Research is ongoing to explore its bioavailability and efficacy in clinical settings.